Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 9:52 pm Purchase | 2025-12-31 | 13G | Citius Oncology, Inc. CTOR | ARMISTICE CAPITAL LLC | 8,078,404 9.990% | 402,493 (+5.24%) | Filing History |
| 2025-12-17 4:10 pm Unchanged | 2025-12-10 | 13D | Citius Oncology, Inc. CTOR | Citius Pharmaceuticals Inc. CTXR | 66,049,615 77.900% | 0 (Unchanged) | Filing History |
| 2025-11-14 6:41 pm Purchase | 2025-09-30 | 13G | Citius Oncology, Inc. CTOR | ARMISTICE CAPITAL LLC | 7,675,911 9.790% | 7,675,911 (New Position) | Filing History |
| 2025-09-12 4:15 pm Unchanged | 2025-09-10 | 13D | Citius Oncology, Inc. CTOR | Citius Pharmaceuticals Inc. CTXR | 66,049,615 79.100% | 0 (Unchanged) | Filing History |
| 2025-07-25 5:00 pm Purchase | 2025-07-17 | 13D | Citius Oncology, Inc. CTOR | Citius Pharmaceuticals Inc. CTXR | 66,049,615 84.300% | 66,049,615 (New Position) | Filing History |
| 2024-11-06 5:08 pm Unchanged | 2024-11-06 | 13G | Citius Oncology, Inc. CTOR | Hudson Bay Capital Management LP | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-09-05 09:23 am Unchanged | 2024-09-05 | 13G | Citius Oncology, Inc. CTOR | WOLVERINE ASSET MANAGEMENT LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-08-16 4:34 pm Unchanged | 2024-08-16 | 13D | Citius Oncology, Inc. CTOR | Citius Pharmaceuticals Inc. CTXR | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-08-15 12:53 pm Unchanged | 2024-08-15 | 13D | Citius Oncology, Inc. CTOR | 10XYZ Holdings LP | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-03-07 4:06 pm Unchanged | 2024-03-07 | 13G | Citius Oncology, Inc. CTOR | Karpus Management Inc. | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-02-13 8:09 pm Unchanged | 2024-02-13 | 13G | Citius Oncology, Inc. CTOR | MIZUHO FINANCIAL GROUP INC MFG | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-02-13 4:07 pm Unchanged | 2024-02-13 | 13G | Citius Oncology, Inc. CTOR | Karpus Management Inc. | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-02-08 4:07 pm Unchanged | 2024-02-08 | 13G | Citius Oncology, Inc. CTOR | WOLVERINE ASSET MANAGEMENT LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-02-05 3:37 pm Unchanged | 2024-02-05 | 13G | Citius Oncology, Inc. CTOR | Space Summit Capital LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-02-14 3:32 pm Unchanged | 2023-02-14 | 13G | Citius Oncology, Inc. CTOR | Feis Lawrence | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-02-10 4:39 pm Unchanged | 2023-02-10 | 13G | Citius Oncology, Inc. CTOR | Hudson Bay Capital Management LP | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-02-08 08:39 am Unchanged | 2023-02-08 | 13G | Citius Oncology, Inc. CTOR | Feis Lawrence | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-02-07 7:48 pm Unchanged | 2023-02-07 | 13G | Citius Oncology, Inc. CTOR | Space Summit Capital LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-10-28 4:59 pm Unchanged | 2022-10-28 | 13D | Citius Oncology, Inc. CTOR | 10XYZ Holdings LP | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-10-20 10:50 am Unchanged | 2022-10-20 | 13G | Citius Oncology, Inc. CTOR | Feis Lawrence | 0 0.000% | 0 (Unchanged) | Filing |